The bill introduces the Kratom Consumer Protection Act (KCPA) to Title 21 of the General Laws, which regulates the distribution and sale of kratom products. It defines terms such as "kratom product," "processor," and "retailer," and sets forth limitations on kratom products, prohibiting the sale of adulterated or contaminated kratom, products with certain levels of alkaloids, synthetic alkaloids, and products without adequate labeling. It also establishes an age limit, prohibiting the sale of kratom products to individuals under 21 years of age.

The bill requires processors and retailers to register kratom products annually, with a fee to cover administrative costs, and to provide a certificate of analysis from a certified independent third-party laboratory. It outlines procedures for non-compliance and adverse event reports, and allows for third-party verification of products. Violations of the KCPA provisions can result in administrative fines ranging from $500 to $1,000, and repeated violations can lead to revocation of a retailer's registration. Additionally, the bill subjects kratom products to sales and use tax and removes mitragynine and 7-hydroxymitragynine from the list of controlled substances under Rhode Island law. The act is set to take effect on January 1, 2024.